683 Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-39,744
| Closed | -$994K | – | 353 |
|
|
2021
Q3 | $994K | Sell |
39,744
-1,016
| -2% | -$25.4K | 0.04% | 132 |
|
|
2021
Q2 | $2.58M | Buy |
+40,760
| New | +$2.58M | 0.09% | 101 |
|
|
2021
Q1 | – | Sell |
-82,902
| Closed | -$9.43M | – | 223 |
|
|
2020
Q4 | $9.43M | Hold |
82,902
| – | – | 0.45% | 41 |
|
|
2020
Q3 | $9.91M | Buy |
82,902
+5,816
| +8% | +$695K | 0.73% | 28 |
|
|
2020
Q2 | $9.6M | Buy |
77,086
+49,341
| +178% | +$6.15M | 0.77% | 22 |
|
|
2020
Q1 | $5.35M | Buy |
+27,745
| New | +$5.35M | 0.63% | 31 |
|